NCT00449813 - The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2008

Conditions

Gastroesophageal Reflux DiseaseNon-erosive Reflux Disease

Interventions

DRUG

Pantoprazole

40 mg Pantoprazole

Trial Locations (15)

Altana Pharma/Nycomed, Sion

Altana Pharma/Nycomed, Biel/Bienne

Altana Pharma/Nycomed, Thun

Altana Pharma/Nycomed, Basel

Altana Pharma/Nycomed, Basel

Altana Pharma/Nycomed, Reinach

Altana Pharma/Nycomed, BT Oss

Altana Pharma/Nycomed, EH Geldrop

Altana Pharma/Nycomed, Lucerne

Altana Pharma/Nycomed, Lucerne

Altana Pharma/Nycomed, Locarno, TI.

Altana Pharma/Nycomed, Zurich

Altana Pharma/Nycomed, Bülach

Altana Pharma/Nycomed, Winterthur

Altana Pharma/Nycomed, Den Helder